CLINICAL_TRIALS
ClinicalTrials.gov record update
A First in Human Phase I Trial of Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR T Cells in Patients With Advanced HER2 Positive Solid Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03740256
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:28.998530+00:00
- Published At
- 2026-02-06T00:00:00+00:00
- Record Updated At
- 2026-02-06
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Bladder Cancer", "Head and Neck Squamous Cell Carcinoma", "Cancer of the Salivary Gland", "Lung Cancer", "Breast Cancer", "Gastric Cancer", "Esophageal Cancer", "Colorectal Cancer", "Pancreatic Adenocarcinoma", "Solid Tumor"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-06"- protocolSection.identificationModule.nctId
"NCT03740256"- protocolSection.identificationModule.officialTitle
"A First in Human Phase I Trial of Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR T Cells in Patients With Advanced HER2 Positive Solid Tumors"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.